Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05227)

• Formulation Name: Dapagliflozin 5 mg tablet
• Company: AstraZeneca

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dapagliflozin	(DM28UJG)	Non-insulin dependent diabetes	5A11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent